Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days
Dyne Therapeutics, Inc. (Nasdaq: DYN) is set to participate in a fireside chat at Stifel 2024 Virtual CNS Days on March 20, 2024. The company focuses on developing therapeutics for genetically driven diseases.
03/13/2024 - 07:30 AM
WALTHAM, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that management is scheduled to participate in a fireside chat at the Stifel 2024 Virtual CNS Days on Wednesday, March 20, 2024 at 8:30 a.m. ET.
A live webcast will be available in the Investors & Media section of Dyne’s website at https://investors.dyne-tx.com/news-and-events/events-and-presentations and a replay will be accessible for 90 days following the presentation.
About Dyne Therapeutics
Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue. Dyne has a broad pipeline for serious muscle diseases, including clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD) and a preclinical program for facioscapulohumeral muscular dystrophy (FSHD). For more information, please visit https://www.dyne-tx.com/ , and follow us on X , LinkedIn and Facebook .
Contact:
Dyne Therapeuticsareilly@dyne-tx.com
When is Dyne Therapeutics scheduled to participate in a fireside chat?
Dyne Therapeutics is scheduled to participate in a fireside chat at Stifel 2024 Virtual CNS Days on Wednesday, March 20, 2024 at 8:30 a.m. ET.
What is Dyne Therapeutics' focus area?
Dyne Therapeutics focuses on advancing innovative life-transforming therapeutics for people living with genetically driven diseases.
Where can investors watch the live webcast of the fireside chat?
Investors can watch the live webcast of the fireside chat in the Investors & Media section of Dyne's website at https://investors.dyne-tx.com/news-and-events/events-and-presentations.
Dyne Therapeutics Inc
NASDAQ:DYN
DYN Rankings
#4413 Ranked by Stock Gains
DYN Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Commercial Services, Miscellaneous Commercial Services, Health Technology, Biotechnology
Country
US
City
Waltham
About DYN
dyne therapeutics, inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the united states. it develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its force platform that delivers disease-modifying therapies. the company was founded in 2017 and is based in waltham, massachusetts.
